Author Archives: Lillian

Featured Stories
Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

FDA Metal-On-Metal Hip Replacement Investigation Is Flawed, Researchers Say

The U.S. Food & Drug Administration’s (FDA) metal-on-metal hip replacement investigation is flawed, according to researchers.

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

Majority of Metal-on-Metal Hip Implant Failures Occur within Two Years, Study Finds

A newly published metal-on-metal hip replacement study is reporting that the majority of failures occur early, within two years of surgery. The study, published in the journal Orthopedics, is just the latest to indicate that close follow-up of metal-on-metal hip implant patients is warranted.

Read More

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

Bisphosphonate Study Confirms Atypical Thigh Fracture Risk

New research has confirmed the link between bisphoshonates, such as Fosamax, and atypical femur fractures, a type of thigh fracture that occurs spontaneously, without any major leg injury. The study, published in the Archives of Internal Medicine, also found that the risk of atypical thigh fractures increases the longer a ...

Read More

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

Toxic Nano-Particles from Failing Metal-on-Metal Hip Replacements May Pose Long-Term Health Risks

According to a new study, failing metal-on-metal hip implants generate toxic nano-particles that release Cobalt 2+ ions, which not only cause inflammation in surrounding tissue, but have the potential to cause long-term damage to the genetic material of cells. According to a report published by Medicalxpress.com, this “genotoxicity” could ...

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Lawsuits Claiming NuvaRing Causes Blood Clots Continue to Build

NuvaRing is being linked to a series of thrombotic issues leading to serious health problems and litigation. The birth contol device can allegedly cause blood clots, some of which can be fatal. Manufacturers such as Merck & Co. are being … Continue reading

Posted in NuvaRing, Pharmaceuticals |

Health Concerns and Litigation over Yaz/Yasmin Birth Control

Bayer is being widely criticized over Yaz and Yasmin, two similar types of oral contraceptives. The popular birth control pills are reportedly responsible for causing blood-clots, with some instances resulting in death. In light of the evidence, advisors to the … Continue reading

Posted in Pharmaceuticals, Yaz / Yasmin |

Actos Linked to Bladder Cancer

Takeda’s Actos, the diabetes drug, has been linked to possible cases of bladder cancer. After studies established a connection between the drug and disease, the widely used medication was taken off the shelves in two European countries last June. Shortly … Continue reading

Posted in Actos, Pharmaceuticals |

Prior to Hip Implant Recall, DePuy Discussed FDA Concerns

Over the past few years, DePuy Orthopaedics has experienced several setbacks concerning their artificial hip implants. The company, which is a subsidiary of Johnson & Johnson, had recalled two of their products in September 2010 due to a high rate … Continue reading

Posted in Defective Medical Devices, Depuy, Metal Hip Implants |

Depakote Legal Troubles Not Over for Abbott

Depakote continues to pose more legal challenges for Abbott Laboratories (ABT). Among other issues, the company has allegedly violated consumer protection laws in relation to Depakote’s sale and marketing. After allegations of off-market labeling and U.S. Justice Department investigation last … Continue reading

Posted in Depakote, Pharmaceuticals |

Medtronic Spine Sales Still Steadily Dropping in Wake of Infuse Controversies

Medtronic, Inc., sales have continued to decline after months of skepticism surrounding some of their products and practices. The company is experiencing a particularly bad quarter with regards to implantable heart defibrillators and spine products, which are two of their … Continue reading

Posted in Defective Medical Devices, Medtonic Infuse |

MS Drug Gilenya Under Review in Europe, but Still Deemed Safe by FDA

US medical professionals are continuing to back Novartis’ Gilenya (fingolimod) despite the growing concern following several cases of patient death in the past few months. To investigate the effects of Gilenya on one’s cardiovascular health, the European Medicines Agency (EMA) … Continue reading

Posted in Gilenya, Pharmaceuticals |